Among Antibody-Like Molecules, Monobodies, Able to Interact with Nucleocapsid Protein of SARS-CoV Virus, There Are Monobodies with High Affinity to Nucleocapsid Protein of SARS-CoV-2 Virus
- PMID: 35538285
- PMCID: PMC9090304
- DOI: 10.1134/S1607672922020077
Among Antibody-Like Molecules, Monobodies, Able to Interact with Nucleocapsid Protein of SARS-CoV Virus, There Are Monobodies with High Affinity to Nucleocapsid Protein of SARS-CoV-2 Virus
Abstract
Seven amino acid sequences of antibody mimetics molecules, monobodies, capable of interacting with the nucleocapsid protein of the SARS-CoV virus, were taken from the literature. Nucleotide sequences of monobody genes were obtained by gene synthesis, which were expressed in E. coli and isolated using Ni-NTA chromatography. It was shown by thermophoresis that three of the seven selected antibody-like molecules can interact with high affinity (dissociation constant of tens of nM) with the nucleocapsid protein of the SARS-CoV-2 virus. For the remaining four monobodies, only low affinity binding with a dissociation constant of several μM was found.
Keywords: SARS-CoV; SARS-CoV-2; antibody-like molecules; monobody; nucleocapsid protein; thermophoresis.
© 2022. Pleiades Publishing, Ltd.
Conflict of interest statement
The authors declare that they have no conflicts of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.
Figures

Similar articles
-
Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells.Dokl Biochem Biophys. 2022 Oct;506(1):220-222. doi: 10.1134/S1607672922050088. Epub 2022 Oct 27. Dokl Biochem Biophys. 2022. PMID: 36303056 Free PMC article.
-
Modular Nanotransporters Capable of Binding to SARS-CoV-2 Virus Nucleocapsid Protein in Target Cells.Dokl Biochem Biophys. 2023 Jun;510(1):87-90. doi: 10.1134/S1607672922600233. Epub 2023 Aug 15. Dokl Biochem Biophys. 2023. PMID: 37582868
-
Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern.Life Sci Alliance. 2022 Mar 7;5(6):e202101322. doi: 10.26508/lsa.202101322. Print 2022 Jun. Life Sci Alliance. 2022. PMID: 35256514 Free PMC article.
-
Properties of Coronavirus and SARS-CoV-2.Malays J Pathol. 2020 Apr;42(1):3-11. Malays J Pathol. 2020. PMID: 32342926 Review.
-
The utility of SARS-CoV-2 nucleocapsid protein in laboratory diagnosis.J Clin Lab Anal. 2022 Jul;36(7):e24534. doi: 10.1002/jcla.24534. Epub 2022 Jun 3. J Clin Lab Anal. 2022. PMID: 35657146 Free PMC article. Review.
Cited by
-
Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells.Dokl Biochem Biophys. 2022 Oct;506(1):220-222. doi: 10.1134/S1607672922050088. Epub 2022 Oct 27. Dokl Biochem Biophys. 2022. PMID: 36303056 Free PMC article.
-
Intracellular Degradation of SARS-CoV-2 N-Protein Caused by Modular Nanotransporters Containing Anti-N-Protein Monobody and a Sequence That Recruits the Keap1 E3 Ligase.Pharmaceutics. 2023 Dec 19;16(1):4. doi: 10.3390/pharmaceutics16010004. Pharmaceutics. 2023. PMID: 38276482 Free PMC article.
References
-
- Wu, C. and Zheng, M., Preprints, 2020, no. 2020020247.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous